Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? have?

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? has 67 citations in the OpenAlex counts ScholarIQ stores.

When was Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? published?

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? has 2018 year in the ScholarIQ index.

What is the open-access status of Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor??

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? has closed oa status in the ScholarIQ index.

What is the DOI of Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor??

The DOI for Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? is on the source record.

What is the PMID of Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor??

The PMID for Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? is on the source record.

What is the OpenAlex record for Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor??

The OpenAlex for Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? is on the source record.